Diese Seite ist nicht auf Deutsch verfügbar. Hier gelangen Sie zur deutschen Homepage.

This page isn’t available in English. Here, you’ll get to the English homepage.


Esta página no está disponible en español - Aquí podrá acceder a la página web en español.

Questa pagina non è disponibile in italiano. Qui si accede alla homepage in italiano.

Cette page n’est pas disponible en français. Ce lien vous conduira à la page d'accueil en français.

해당 페이지는 한국어가 지원되지 않습니다. 이 곳을 클릭하시면 한국어 버전 홈페이지로 이동하게 됩니다.

Contact vCard

P +49 (0) 89 92 40 90

Arabellastraße 30
81925 Munich

For security reasons we give you the possibility to communicate with Daniel Offenbartl-Stiegert in an encrypted form by e-mail.


Daniel Offenbartl-Stiegert

PhD (Chemistry), MRes, BA


Languages: German, English, French


Patent prosecution and oppositions before the European Patent Office (EPO) as well as drafting new patent applications. Broad technical expertise across the fields of biotechnology and organic chemistry, especially in nucleic acid-based technologies, e.g. DNA nanotechnology, RNAi, antisense, nucleic acid modifications.


Numerous first- and co-author publications in scientific journals e.g. Journal of the American Chemical Society, Angewandte Chemie und Nature Protocols.


Obtained a bachelor’s degree in chemistry with specialisation in organic and biological chemistry at the University of Cambridge (2012-2015) followed by an MRes at University College London (2015-2016). Then, attained a Doctorate at University College London in chemical biology with a focus on DNA nanotechnology (2016-2020). Specifically, the design of DNA nanopores and their use, for example in targeted drug delivery. Further research in the development and synthesis of photo-responsive protecting groups and their applications, e.g. for targeted, epigenetic modulation of DNA. With HOFFMANN EITLE since 2020.